TY  - JOUR
AU  - Cantarin-Extremera, V.
AU  - Jimenez-Legido, M.
AU  - Aguilera-Albesa, S.
AU  - Hedrera-Fernandez, A.
AU  - Arrabal-Fernandez, L.
AU  - Gorria-Redondo, N.
AU  - Marti-Carrera, I.
AU  - Yoldi-Pedtri, M. E.
AU  - Gonzalez-Gutierrez-Solana, L.
AU  - Sagaseta-De Ilurdoz, M.
PY  - 2023
DO  - 10.1016/j.nrl.2020.04.025
SN  - 0213-4853
UR  - https://hdl.handle.net/10668/26269
T2  - Neurologia
AB  - Introduction: Opsoclonus-myoclonus-ataxia syndrome is a rare neuroinflammatory disorderwith onset during childhood; aetiology may be paraneoplastic, para-infectious, or idiopathic. No biomarkers have yet been identified, and diagnosis is clinical....
LA  - en
PB  - Elsevier espana slu
KW  - Opsoclonus-myoclonus-ataxia syndrome
KW  - Neuroinflammation
KW  - Immunotherapy
KW  - MIBG
KW  - Neuroblastoma
KW  - Neurocognitive
KW  - Follow-up
KW  - Neuroblastoma
KW  - Ataxia
KW  - Children
KW  - Diagnosis
KW  - Features
TI  - Opsoclonus-myoclonus syndrome: clinical characteristics, therapeutic considerations, and prognostic factors in a Spanish paediatric cohort
TY  - research article
VL  - 38
ER  -